Pingping Lin - The Affiliated Hospital, Qingdao University

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 37 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2010, a Novel Anti-Masp-2 Antibody, in Healthy Volunteers: a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study

Pingping Lin,Chenjing Wang, Xiaotong Hu, Lin Fang, Hongda Lin, Feifei Sun, Rong Huang, Rongxin Ban, Sheng Feng, Zhenyan Gao,Kai Shen,Yu Cao

Expert opinion on investigational drugsno. 4 (2025): 339-348

引用0浏览0WOS引用

Safety and Pharmacokinetic Profiles of a Humanized Monoclonal Antibody TQH2722 Targeting Interleukin 4 Receptor Alpha (Il-4Rα) in Health Adult Subjects

Pingping Lin,Feifei Sun,Yi Xu, Rongxin Ban,Xin Jiang,Yao Fu,Xiaomeng Gao,Yu Cao

BRITISH JOURNAL OF DERMATOLOGY（2024）

引用0浏览0引用

565 – Safety and Pharmacokinetic Profiles of a Humanized Monoclonal Antibody TQH2722 Targeting Interleukin 4 Receptor Alpha (Il-4Rα) in Health Adult Subjects

Pingping Lin,Feifei Sun,Yi Xu, Rongxin Ban,Xin Jiang,Yao Fu,Xiaomeng Gao,Yu Cao

British Journal of Dermatologyno. Supplement_2 (2024)

引用0浏览0引用

Tolerability, Safety, and Pharmacokinetics of a Single Intravenous Administration of a Novel Recombinant Humanized Anti-Interleukin-6 Receptor Monoclonal Antibody in Healthy Chinese Volunteers

Xin Jiang,Pingping Lin,Feifei Sun,Yi Xu,Ye Tao,Ping Shi,Yanping Liu,Xin Li,Shuqin Liu,Xiaomeng Gao,Chenjing Wang,Yu Cao

Frontiers in Pharmacology (2024)

引用0浏览0WOS引用

Pharmacokinetics and Safety Profiles of Beinaglutide Injection, a Recombinant Human GLP-1, in Adults with Overweight/obesity: Results from a Phase I Clinical Trial

Pingping Lin,Chengqian Li,Yanping Liu,Feifei Sun,Tsung-Han Hsieh,Yaping Ma,Xiaomeng Gao,Qing Yu,Yu Cao

Frontiers in Pharmacology (2024)

引用0浏览0WOS引用

First-in-Human Safety, Tolerability and Pharmacokinetics of a Novel Drug with Therapeutic Potential for Vascular Dementia, Naoqingzhiming Tablet: Results from Single Ascending Doses Studies in Healthy Chinese Subjects

Ping-ping Lin, Ye Tao,Feifei Sun, Xin Jiang, Ting Li, Xin Liu,Mingxia Chen, Haiyan Jiang, Fanli Yan,Yahui Han,Yu Cao

openalex（2024）

引用0浏览0引用

A Drug–Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients with Primary Hyperuricemia

Chenjing Wang,Qing Yu,Xin Jiang,Yujie Deng,Feifei Sun,Xin Li,Ye Tao,Pingping Lin,Yaping Ma, Yuxian Zhu,Chengqian Li,Yu Cao

JOURNAL OF CLINICAL PHARMACOLOGY（2023）

引用3浏览0WOS引用

Pharmacokinetics and Bioequivalence of Ezetimibe Tablet Versus Ezetrol®:an Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects

Feifei Sun,Yanping Liu,Ting Li,Pingping Lin,Xin Jiang,Xin Li,Chenjing Wang,Xiaomeng Gao,Yaping Ma,Yao Fu,Yu Cao

BMC Pharmacology and Toxicology（2023）

引用3浏览0WOS引用

Pharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Two Doses in Healthy Chinese Subjects

Xin Li,Chenjing Wang,Ping Shi,Yanping Liu,Ye Tao,Pingping Lin,Ting Li,Haixun Hu,Feifei Sun,Shuqin Liu,Yao Fu,Yu Cao

BMC Pharmacology and Toxicology（2023）

引用1浏览0WOS引用

Randomized, Double-Blind, Placebo-Controlled, Phase I, Dose- Escalation Study to Evaluate the Tolerance, Pharmacokinetics, Pharmacodynamics and Immunogenicity of PEGylated Urate Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers: Study Protocol

Feifei Sun,Chenjing Wang,Yi Xu,Pingping Lin, Yaozhong Cao, Jiahui Zhang,Xin Li,Xin Jiang,Yao Fu,Yu Cao

DIABETES METABOLIC SYNDROME AND OBESITY (2023): 4263-4268

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn